Please login to the form below

Not currently logged in
PMLiVE Top Pharma List

Sumitomo Dainippon

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Sumitomo Dainippon 's Japan sales performance.


Sanofi agrees €250m diabetes deal with AI firm Exscientia

Sanofi agrees €250m diabetes deal with AI firm Exscientia s Sumitomo Dainippon Pharma on psychiatric disease collaboration, and with Sunovion on undisclosed central nervous system (CNS) targets.

Deal Watch December 2016

Deal Watch December 2016 790. Tolero Pharma (US). Dainippon Sumitomo (Japan). Acquisition with milestones. Portfolio, including alvocidib, a CDK9 inhibitor with phase II completed in AML. ... Tolero Pharmaceuticals. Dainippon Sumitomo. $780m. Upfront payment of $200m.

Deal Watch August 2016

Deal Watch August 2016 If apomorphine is the only product, the acquisition of the company by Sunovion (the US subsidiary of Dainippon Sumitomo) for $645m, paying a hefty 123% share price premium, looks very expensive ... 645. Cynapsys (CA). Sunovion (US) (Dainippon Sumitomo).

FDA panel backs Intercept's rare liver disease drug

FDA panel backs Intercept's rare liver disease drug Intercept owns worldwide rights to Ocaliva outside Japan and China, where it has out-licensed the drug to Sumitomo Dainippon Pharma.

Deal Watch table for March 2014

Deal Watch table for March 2014 105. Sumitomo Chemical/ AstraZeneca. Acquisition of remaining shares. AZ takes complete control of AstraZeneca KK.

[ Previous 5 results ] 1 2 3 4 5 6 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs


Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Is communication failing us?
Compelling people to care in a world oversaturated with news and information...
Are your field teams ready to excel in the new era?
A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs....
5 Healthcare Marketing Blunders | How To Avoid Them.
Here are 5 healthcare marketing blunders and how best to avoid them....